Cascade Biotechnology is developing therapeutics that use the body's complement system to attack diseases and disorders such as Alzheimer's disease (AD), schizophrenia (SZ), myasthenia gravis (MG), Neuromyelitis Optica (NMO), cancer, adult macular degeneration (ADM), blood diseases such as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS) and others. The complement system is an important part of the innate immune system, which helps to protect the host against infection and connects innate and adaptive immune systems. Complement consists of more than 30 proteins that are activated through a series of proteolytic cleavages, which in turn activate proteins in the next step of the complement cascade. There are three complement activation pathways, the classical pathway, activated by the presence of antibodies on the cell surface, the lectin pathway, activated by the recognition of certain carbohydrates on cell surfaces, and the Alternative Pathway, which is constantly activated by spontaneous conformational changes to C3, the most common complement protein. All three activation pathways come together through C3 activation. C3 activation allows for the activation of another complement protein, C5, that initiates the terminal complement pathway. This pathway forms the macromolecular Membrane Attack Complex (MAC), which is able to destroy invading pathogens by punching holes in their cellular membrane. While complement proteins serve an important regulatory role in inflammation, over activation of complement ultimately leads to disease states. Inhibiting overactive complement offers one strategy for managing and potentially preventing a range of disease and disorders. See: Fritzinger DC, Benjamin DE (2016) The Complement System in Neuropathic and Postoperative Pain. Open Pain J. (2016);9:26-37.
View Top Employees from Cascade BiotechnologyWebsite | http://www.cascadebiotechnology.com |
Revenue | $1 million |
Employees | 2 (2 on RocketReach) |
Address | 9 Deerpark Dr, Ste K8, Monmouth Junction, New Jersey 08852, US |
Industry | Business Services General, Business Services |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies |
Looking for a particular Cascade Biotechnology employee's phone or email?
The Cascade Biotechnology annual revenue was $1 million in 2024.
2 people are employed at Cascade Biotechnology.
Cascade Biotechnology is based in Monmouth Junction, New Jersey.
The NAICS codes for Cascade Biotechnology are [54, 541713, 54171, 5417, 541].
The SIC codes for Cascade Biotechnology are [873, 87].